• Profile
Close

Serum level of interleukin-22 in patients with cutaneous warts: A case-control study

Journal of Cosmetic Dermatology May 28, 2021

El-Sayed Mahmoud Marie R, Abuzeid AQEM, Attia FM, et al. - Researchers conducted this case-control study to evaluate serum levels of interleukin-22 (IL-22) in patients with warts and its association with their different clinical features. The sample consisted of 20 patients with warts and 20 control individuals. Through enzyme-linked immune sorbent assay, serum concentration of IL-22 was measured. In patients with warts, the serum level of IL-22 was elevated. Patients with recurrent warts after prior treatment had significantly higher levels than patients with first-time warts. Furthermore, a significant positive correlation was found between serum IL-22 levels and the number of warts. As a result, IL-22 may play an important role in the antiviral immune response to this infection.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay